We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+8.77%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.75%
AUM
$19.4B
AUM Growth
+$2.92B
(+18%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
9.31%
Top 10 Holdings %
Top 10 Hldgs %
20.62%
Holding
1,394
New
273
Increased
343
Reduced
316
Closed
453
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$694M |
| 2 |
Philip Morris
PM
|
+$316M |
| 3 |
Johnson & Johnson
JNJ
|
+$315M |
| 4 |
Merck
MRK
|
+$303M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$248M |
| 2 |
Micron Technology
MU
|
+$212M |
| 3 |
RAD
Rite Aid Corporation
RAD
|
+$196M |
| 4 |
Comcast
CMCSA
|
+$165M |
| 5 |
GSK
GSK
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.45% |
| 2 | Energy | 18.88% |
| 3 | Healthcare | 17.92% |
| 4 | Financials | 10.19% |
| 5 | Consumer Staples | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHK
76
DELISTED
Chesapeake Energy Corporation
CHK
| $58.6M | 0.3% |
9,971
+8,789
| +744% | +$47.9M |
|
77
Xerox
XRX
$411M
| $58.5M | 0.3% |
1,783,455
-1,226,053
| -41% | -$39M |
|
|
BHI
78
DELISTED
Baker Hughes
BHI
| $57.4M | 0.3% |
770,652
+497,301
| +182% | +$34.6M |
|
79
BP
BP
$114B
| $56.1M | 0.29% |
1,301,260
+898,481
| +223% | +$37.1M |
|
80
Mondelez International
MDLZ
$78.8B
| $55.8M | 0.29% |
1,482,969
+1,154,810
| +352% | +$42.2M |
|
|
NBG
81
DELISTED
NATIONAL BANK OF GREECE SA ADR REPSTG 1 SHARE (NEW)
NBG
| $54.6M | 0.28% |
14,845,743
+11,150,028
| +302% | +$44.7M |
|
82
Monster Beverage
MNST
$91.5B
| $53.8M | 0.28% |
4,547,604
-1,188,012
| -21% | -$13.5M |
|
|
DFS
83
DELISTED
Discover Financial Services
DFS
| $53.8M | 0.28% |
867,982
+445,864
| +106% | +$26M |
|
84
FedEx
FDX
$73.2B
| $53.7M | 0.28% |
354,682
+9,027
| +3% | +$1.26M |
|
85
Santander
BSBR
$43B
| $52.7M | 0.27% |
+7,955,003
| New | +$49.4M |
|
86
Magna International
MGA
$18.5B
| $51.6M | 0.27% |
957,394
-2,333,184
| -71% | -$119M |
|
87
TotalEnergies
TTE
$194B
| $51.6M | 0.27% |
+714,016
| New | +$50M |
|
88
Berkshire Hathaway Class A
BRK.A
$1.1T
| $49.9M | 0.26% |
+263
| New | +$49.9M |
|
|
RDS.A
89
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $49.7M | 0.26% |
+603,543
| New | +$47.2M |
|
90
Skyworks Solutions
SWKS
$9.22B
| $49.6M | 0.26% |
1,056,699
+379,352
| +56% | +$16M |
|
91
PG&E
PCG
$38.4B
| $48.7M | 0.25% |
1,014,639
-370,297
| -27% | -$16.8M |
|
92
Walt Disney
DIS
$170B
| $48.3M | 0.25% |
563,306
+266,902
| +90% | +$21.8M |
|
93
Sanofi
SNY
$103B
| $46.8M | 0.24% |
881,056
-537,243
| -38% | -$28.5M |
|
94
Murphy Oil
MUR
$5.55B
| $46.4M | 0.24% |
697,949
+679,273
| +3,637% | +$42.6M |
|
95
DTE Energy
DTE
$29.5B
| $46.3M | 0.24% |
698,293
+64,836
| +10% | +$4.21M |
|
96
Ameren
AEE
$30.3B
| $46M | 0.24% |
1,126,415
+660,839
| +142% | +$26.3M |
|
97
Sabesp
SBS
$19B
| $45.7M | 0.24% |
22,001,536
+1,701,127
| +8% | +$3.26M |
|
98
ExxonMobil
XOM
$643B
| $45.6M | 0.23% |
+452,988
| New | +$45.7M |
|
99
Cognizant
CTSH
$24.9B
| $45.5M | 0.23% |
929,903
+881,629
| +1,826% | +$43M |
|
100
Cummins
CMI
$89.5B
| $45.1M | 0.23% |
+292,015
| New | +$44.2M |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2014 Portfolio in Review
As of Q2 2014, Arrowstreet Capital held 1,394 positions worth $19.4B, up 18% from $16.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Arrowstreet Capital deployed $1.81B of net new capital in Q2 2014, opening 273 new positions and adding to 343 existing holdings. Its largest new stake was Johnson & Johnson: 3,117,484 shares worth $326M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $248M trimmed.
- Arrowstreet Capital's largest Q2 2014 buy was Johnson & Johnson: 3,117,484 shares worth $326M.
- Arrowstreet Capital added most to Apple in Q2 2014, an estimated $694M increase.
- Arrowstreet Capital's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $248M.
- Arrowstreet Capital fully exited Comcast in Q2 2014, selling an estimated $165M.
- Arrowstreet Capital's ten largest holdings make up 21% of its $19.4B portfolio in Q2 2014.
- Arrowstreet Capital opened 273 new positions and closed 453 in Q2 2014.
- Arrowstreet Capital's portfolio value rose 18% quarter-over-quarter to $19.4B.
Based on Arrowstreet Capital's 13F filing for Q2 2014, filed 14 Aug 2014.